Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 2/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL245018 | 0.87 | POLB (0.39) | POLBLMNAHPGDSMN1; SMN2ATM | |
| SCHEMBL3248433 | 0.80 | POLB (0.36) | POLBLMNAHPGDSMN1; SMN2ATM | |
| SCHEMBL158980 | 0.75 | POLB (0.41) | POLBLMNAHPGDSMN1; SMN2ATM | |
| SCHEMBL245976 | 0.71 | POLB (0.42) | POLBHPGDSMN1; SMN2ATMNPC1 | |
| SCHEMBL7708642 | 0.71 | POLB (0.39) | POLBHPGDATM | |
| SCHEMBL32688585 | 0.69 | POLB (0.42) | POLBLMNAHPGDSMN1; SMN2ATM | |
| SCHEMBL32688828 | 0.69 | POLB (0.36) | POLBLMNAHPGDSMN1; SMN2ATM | |
| SCHEMBL6396833 | 0.69 | POLB (0.40) | POLBHPGDSMN1; SMN2ATMNPC1 | |
| SCHEMBL7940071 | 0.68 | POLB (0.40) | POLBHPGDATM | |
| SCHEMBL703642 | 0.68 | POLB (0.42) | POLBLMNAHPGDSMN1; SMN2ATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030211421-A1 | Optically active compound and photosensitive resin composition | KRI, INC. (JP) | 2003-11-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030211421-A1 | Optically active compound and photosensitive resin composition | ARCN1, RAD51, PAM | POLB 2346/4885LMNA 202/4885HPGD 146/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.